- SEK3.99bn
- SEK3.72bn
- SEK627.69m
Brief: Probi Q4 Operating Profit Rises To SEK 30.6 Million
Brief: Probi Appoints Henrik Lundkvist As CFO
Swedish stocks: Seen opening lower, Hexagon earnings top forecasts
Brief: Probi Q3 Operating Profit Up At SEK 37.9 Mln; New CEO
Swedish stocks: seen opening lower, Berenberg trims Assa Abloy target price
Brief: Probi Q2 Operating Profit Falls To SEK 28.2 Million
Brief: Probi CFO To Resign
Swedish stocks: Seen opening higher, Berenberg lifts view on Assa Abloy
Brief: Probi Q1 Net Sales Fall To SEK 119.2 Million
Brief: Probi: Positive Results Of Probi's Probiotic Supplement
Brief: Probi Signs Long-Term Agreement With Cilag
Brief: Probi Appoints Ole Søgaard Andersen As Interim CEO
Brief: Probi: Clinical Trial Confirms Immune Enhancing Impact Of Probi Defendum
Brief: Probi Q4 Net Sales At SEK 119.4 Mln
Brief: Probi Signs Agreement For Product Launch In North America
Brief: Probi Q3 operating profit down at SEK 16.6 million
Brief: Probi says no longer expects to hit organic growth goal in 2017
Brief: Probi: Q2 net sales at SEK 172 million
Brief: Probi Q1 operating profit rises to SEK 56.0 million